Woburn, Massachusetts–based NeuroMetrix designed DPNCheck 2.0 to use nerve conduction technology to detect peripheral neuropathy.
DPNCheck 2.0 provides rapid patient screening with quantitative measurement of peripheral nerve function. It features an easy-to-use touchscreen, step-by-step onboarding instructions and improved temperature compensation. Additionally, it offers real-time nerve response display and other enhancements, with companion software for facilitating clinical documentation of test results.
The company plans to add cloud-based aggregation of population-health data and integration with provider EHR systems this year.
NeuroMetrix said that its nerve conduction technology allows for the potential uncovering of an elevated risk for complications from peripheral neuropathy. It said it aims to catch…